This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reddy, J. K. Articles by Moehle, C. M. Search for Related Content PubMed PubMed Citation Articles by Reddy, J. K. Articles by Moehle, C. M.

American Journal of Pathology, Vol 114, 171-183, Copyright © 1984 by American Society for Investigative Pathology

REGULAR ARTICLES

Induction of hepatic peroxisome proliferation in nonrodent species, including primates

JK Reddy, ND Lalwani, SA Qureshi, MK Reddy and CM Moehle

It is well established that the administration to rodents of a variety of structurally diverse chemicals possessing hypotriglyceridemic properties results in hepatomegaly, the induction of hepatic peroxisome (microbody) proliferation, and the development of hepatocellular carcinomas. Studies have led to the hypothesis that persistent proliferation of peroxisomes serves as an endogenous initiator of neoplastic transformation in liver by increasing the intracellular production of H2O2 by the peroxisomal oxidase(s). The objective of the present study was to determine whether hepatic peroxisome proliferation can be induced in cats, chickens, pigeons, and two species of monkeys (rhesus and cynomolgus). The hypolipidemic drug ciprofibrate (2-[4-(2,2- dichloro-cylopropyl)phenoxyl]2-methylpropionic acid) induced peroxisome proliferation in the livers of cats (dose, greater than 40 mg/kg body weight for 4 weeks); chickens (dose greater than 25 mg/kg body weight for 4 weeks); pigeons (300 mg/kg body weight for 3 weeks), rhesus monkeys (50 to 200 mg/kg body weight for 7 weeks) and cynomolgus monkeys (400 mg/kg body weight for 4 weeks). In all five species examined in this study, a marked but variable increase in the activities of peroxisomal catalase, carnitine acetyltransferase, heat- labile enoyl-CoA hydratase, and the fatty acid beta-oxidation system was observed. These results suggest that peroxisome proliferation can be induced in the livers of several species and that it is a dose- dependent but not a species-specific phenomenon.

This article has been cited by other articles:

				N. F. Cariello, E. H. Romach, H. M. Colton, H. Ni, L. Yoon, J. G. Falls, W. Casey, D. Creech, S. P. Anderson, G. R. Benavides, et al. Gene Expression Profiling of the PPAR-alpha Agonist Ciprofibrate in the Cynomolgus Monkey Liver Toxicol. Sci., November 1, 2005; 88(1): 250 - 264. [Abstract] [Full Text] [PDF]

				D. J. Hoivik, C. W. Qualls Jr, R. C. Mirabile, N. F. Cariello, C. L. Kimbrough, H. M. Colton, S. P. Anderson, M. J. Santostefano, R. J. O. Morgan, R. R. Dahl, et al. Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys Carcinogenesis, September 1, 2004; 25(9): 1757 - 1769. [Abstract] [Full Text] [PDF]

				H. M. Colton, J. G. Falls, H. Ni, P. Kwanyuen, D. Creech, E. McNeil, W. M. Casey, G. Hamilton, and N. F. Cariello Visualization and Quantitation of Peroxisomes Using Fluorescent Nanocrystals: Treatment of Rats and Monkeys with Fibrates and Detection in the Liver Toxicol. Sci., July 1, 2004; 80(1): 183 - 192. [Abstract] [Full Text] [PDF]

				J. M. Peters, I. Rusyn, M. L. Rose, F. J. Gonzalez, and R. G. Thurman Peroxisome proliferator-activated receptor {alpha} is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis Carcinogenesis, April 1, 2000; 21(4): 823 - 826. [Abstract] [Full Text] [PDF]

				C. L. Bisgaier, A. D. Essenburg, B. C. Barnett, B. J. Auerbach, S. Haubenwallner, T. Leff, A. D. White, P. Creger, M. E. Pape, T. J. Rea, et al. A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor J. Lipid Res., January 1, 1998; 39(1): 17 - 30. [Abstract] [Full Text]